Publication Information

{'id': 'https://openalex.org/W2765200435', 'doi': 'https://doi.org/10.1056/nejm-jw.na45298', 'title': 'Pioglitazone vs. Sulfonylurea as Add-On Treatment for Type 2 Diabetes', 'display_name': 'Pioglitazone vs. Sulfonylurea as Add-On Treatment for Type 2 Diabetes', 'publication_year': 2017, 'publication_date': '2017-10-26', 'ids': {'openalex': 'https://openalex.org/W2765200435', 'doi': 'https://doi.org/10.1056/nejm-jw.na45298', 'mag': '2765200435'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://www.jwatch.org/na45298/2017/10/26/pioglitazone-vs-sulfonylurea-add-treatment-type-2-diabetes', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764501393', 'display_name': 'Journal watch', 'issn_l': '0896-7210', 'issn': ['0896-7210'], 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/P4310320239', 'host_organization_name': 'Massachusetts Medical Society', 'host_organization_lineage': ['https://openalex.org/P4310320239'], 'host_organization_lineage_names': ['Massachusetts Medical Society'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': [], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5112048102', 'display_name': 'Allan S. Brett', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': True, 'raw_author_name': 'Allan S. Brett', 'raw_affiliation_strings': [], 'affiliations': []}], 'institution_assertions': [], 'countries_distinct_count': 0, 'institutions_distinct_count': 0, 'corresponding_author_ids': ['https://openalex.org/A5112048102'], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 63}, 'biblio': {'volume': '2017', 'issue': None, 'first_page': None, 'last_page': None}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10401', 'display_name': 'Diabetes Treatment and Management', 'score': 0.9966, 'subfield': {'id': 'https://openalex.org/subfields/2712', 'display_name': 'Endocrinology, Diabetes and Metabolism'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10401', 'display_name': 'Diabetes Treatment and Management', 'score': 0.9966, 'subfield': {'id': 'https://openalex.org/subfields/2712', 'display_name': 'Endocrinology, Diabetes and Metabolism'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11072', 'display_name': 'Peroxisome Proliferator-Activated Receptors', 'score': 0.9961, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T11339', 'display_name': 'Metabolism, Diabetes, and Cancer', 'score': 0.9882, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/pioglitazone', 'display_name': 'Pioglitazone', 'score': 0.95440125}, {'id': 'https://openalex.org/keywords/sulfonylurea', 'display_name': 'Sulfonylurea', 'score': 0.93823206}], 'concepts': [{'id': 'https://openalex.org/C2778384471', 'wikidata': 'https://www.wikidata.org/wiki/Q417765', 'display_name': 'Pioglitazone', 'level': 4, 'score': 0.95440125}, {'id': 'https://openalex.org/C2778854520', 'wikidata': 'https://www.wikidata.org/wiki/Q418776', 'display_name': 'Sulfonylurea', 'level': 3, 'score': 0.93823206}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.85750604}, {'id': 'https://openalex.org/C2777180221', 'wikidata': 'https://www.wikidata.org/wiki/Q3025883', 'display_name': 'Type 2 diabetes', 'level': 3, 'score': 0.8194828}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.48129764}, {'id': 'https://openalex.org/C555293320', 'wikidata': 'https://www.wikidata.org/wiki/Q12206', 'display_name': 'Diabetes mellitus', 'level': 2, 'score': 0.39845994}, {'id': 'https://openalex.org/C134018914', 'wikidata': 'https://www.wikidata.org/wiki/Q162606', 'display_name': 'Endocrinology', 'level': 1, 'score': 0.2939679}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://www.jwatch.org/na45298/2017/10/26/pioglitazone-vs-sulfonylurea-add-treatment-type-2-diabetes', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764501393', 'display_name': 'Journal watch', 'issn_l': '0896-7210', 'issn': ['0896-7210'], 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/P4310320239', 'host_organization_name': 'Massachusetts Medical Society', 'host_organization_lineage': ['https://openalex.org/P4310320239'], 'host_organization_lineage_names': ['Massachusetts Medical Society'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'score': 0.8, 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W3205480399', 'https://openalex.org/W3183170789', 'https://openalex.org/W2889345352', 'https://openalex.org/W2806864111', 'https://openalex.org/W2599384821', 'https://openalex.org/W2552604765', 'https://openalex.org/W2543415957', 'https://openalex.org/W2416445012', 'https://openalex.org/W2147764623', 'https://openalex.org/W2139823563', 'https://openalex.org/W2134235461', 'https://openalex.org/W2129193901', 'https://openalex.org/W2120377308', 'https://openalex.org/W2104625118', 'https://openalex.org/W2096739049', 'https://openalex.org/W2035668483', 'https://openalex.org/W2030875546', 'https://openalex.org/W2026259786', 'https://openalex.org/W1965882426', 'https://openalex.org/W1562360472'], 'abstract_inverted_index': {'Recently': [0], 'published': [1], 'trials': [2], 'of': [3], 'drug': [4], 'therapies': [5], 'for': [6], 'type': [7], '2': [8], 'diabetes': [9], 'generally': [10], 'have': [11], 'involved': [12], 'costly': [13], 'new': [14, 18], 'agents.': [15], 'In': [16], 'this': [17], 'randomized': [19], 'trial,': [20], 'researchers': [21], 'in': [22]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2765200435', 'counts_by_year': [], 'updated_date': '2024-12-07T11:59:22.083441', 'created_date': '2017-11-10'}